QT interval prolongation, hydroxychloroquine, azithromycin in hospitalized patients with COVID-19

What The Study Did:

This observational study examines the association of hydroxychloroquine or hydroxychloroquine and azithromycin with QT prolongation in adult patients hospitalized with coronavirus disease 2019 (COVID-19).

Authors:

Howard S. Gold, M.D., of Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, is the corresponding author.

To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/

(doi:10.1001/jamacardio.2020.1834)

Editor’s Note:

Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

###

Media advisory:

The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

https:/

/

jamanetwork.

com/

journals/

jamacardiology/

fullarticle/

10.

1001/

jamacardio.

2020.

1834?guestAccessKey=

ecaa8580-cf8c-41f2-8a5f-1f578fbc6fc4&utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_content=

tfl&utm_term=

050120